Savior LLC Bristol Myers Squibb CO Transaction History

Savior LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 05, 2021	SELL	$59.17 - $69.31 $24,792 - $29,040	-419 Closed	0 $0
Q2 2021 Jul 09, 2021	SELL	$61.91 - $67.42 $18,573 - $20,226	-300 Reduced 41.72%	419 $28,000
Q2 2020 Jul 28, 2020	BUY	$54.82 - $64.09 $8,003 - $9,357	146 Added 25.48%	719 $42,000
Q1 2020 Apr 22, 2020	SELL	$46.4 - $67.43 $1,670 - $2,427	-36 Reduced 5.91%	573 $32,000
Q4 2019 Jan 22, 2020	BUY	$49.21 - $64.19 $29,968 - $39,091	609 New	609 $39,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Savior LLC, based on Form 13F filings with the SEC.

Stay updated on Savior LLC with notifications on news.